Board Meeting Details

  • Meeting Date: Wednesday, November 4, 2026
  • Regulatory Reference: Filed under Regulation 29(1) of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015

Agenda Items

The Board will consider and approve:

  • Unaudited Standalone Financial Results for Q2 and H1 ended September 30, 2026 (FY 2026-27) with Limited Review Report from Statutory Auditors
  • Unaudited Consolidated Financial Results for Q2 and H1 ended September 30, 2026 (FY 2026-27) with Limited Review Report from Statutory Auditors

Trading Window Update

  • Trading Window reopening date: Saturday, November 7, 2026
  • Continuation of earlier intimation dated September 25, 2026
  • Compliance basis: SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct for Designated Persons

Financial Impact

Financial impact not quantified in the disclosure. The meeting is scheduled to review and approve financial results.